Wikidata

(Q40565012)

English

CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo

scientific article published on June 2004

In more languages

Statements

title
CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
author name string
Mohit Trikha
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
Zhao Zhou
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
Jeffrey A Nemeth
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
Qiming Chen
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
Celia Sharp
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
Eva Emmell
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
Jill Giles-Komar
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
Marian T Nakada
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
publication date
1 June 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017
page(s)
326-335
1 reference
stated in
Europe PubMed Central
PubMed ID
15095296
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40565012&oldid=1900600163"